BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,004 filers reported holding BAXTER INTL INC in Q3 2022. The put-call ratio across all filers is 1.55 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $33,450 | -39.8% | 1,000 | -23.1% | 0.01% | -40.9% |
Q1 2024 | $55,549 | +10.6% | 1,300 | 0.0% | 0.02% | +4.8% |
Q4 2023 | $50,245 | +2.4% | 1,300 | 0.0% | 0.02% | -8.7% |
Q3 2023 | $49,049 | -17.2% | 1,300 | 0.0% | 0.02% | -30.3% |
Q2 2023 | $59,228 | -43.3% | 1,300 | -49.5% | 0.03% | -46.8% |
Q1 2023 | $104,442 | -20.4% | 2,575 | 0.0% | 0.06% | -27.1% |
Q4 2022 | $131,246 | -25.0% | 2,575 | -20.8% | 0.08% | -28.0% |
Q3 2022 | $175,000 | -27.4% | 3,250 | -13.3% | 0.12% | -23.9% |
Q2 2022 | $241,000 | -7.3% | 3,750 | +11.9% | 0.16% | -1.3% |
Q1 2022 | $260,000 | -17.5% | 3,350 | -8.7% | 0.16% | -13.7% |
Q4 2021 | $315,000 | +6.8% | 3,670 | 0.0% | 0.18% | -6.2% |
Q3 2021 | $295,000 | -10.1% | 3,670 | -9.9% | 0.19% | -7.6% |
Q2 2021 | $328,000 | +5.8% | 4,075 | +10.9% | 0.21% | -5.4% |
Q1 2021 | $310,000 | +9.5% | 3,675 | +4.3% | 0.22% | +5.2% |
Q4 2020 | $283,000 | +4.4% | 3,525 | +4.4% | 0.21% | +1.0% |
Q3 2020 | $271,000 | -7.5% | 3,375 | -0.7% | 0.21% | -16.4% |
Q2 2020 | $293,000 | -7.9% | 3,400 | -10.5% | 0.25% | -5.3% |
Q4 2019 | $318,000 | -4.2% | 3,800 | 0.0% | 0.26% | -11.7% |
Q3 2019 | $332,000 | +6.8% | 3,800 | 0.0% | 0.30% | +4.9% |
Q2 2019 | $311,000 | +0.6% | 3,800 | 0.0% | 0.28% | -2.4% |
Q1 2019 | $309,000 | -2.2% | 3,800 | -7.3% | 0.29% | +3.5% |
Q3 2018 | $316,000 | +6.4% | 4,100 | 0.0% | 0.28% | +4.4% |
Q2 2018 | $297,000 | +11.2% | 4,100 | 0.0% | 0.27% | +3.8% |
Q1 2018 | $267,000 | +0.8% | 4,100 | 0.0% | 0.26% | +2.4% |
Q4 2017 | $265,000 | – | 4,100 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
13D Management LLC | 200,318 | $14,791,000 | 3.77% |
ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |